Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UK's COVID-19 test-and-trace system still missing targets-watchdog

Published 06/24/2021, 07:17 PM
Updated 06/24/2021, 07:26 PM
© Reuters. FILE PHOTO: A member of NHS Test and Trace staff sets up a mobile testing centre amid the outbreak of the coronavirus disease (COVID-19) in the Moston area of Manchester, Britain, February 17, 2021. REUTERS/Phil Noble/File Photo

By Michael Holden

LONDON (Reuters) - Britain's much-maligned multi-billion pound COVID-19 test-and-trace system has improved, but is still missing targets and the results of millions of tests to find asymptomatic cases have not been reported, parliament's spending watchdog said on Friday.

The programme, which was given a 22 billion pound ($30.6 billion) budget, was launched by Prime Minister Boris Johnson in May 2020 to oversee testing of those who thought they had the virus and then to trace the contacts of those who tested positive.

Critics say it has wasted huge sums and failed in its primary objective of breaking the chain of transmission.

The National Audit Office said the NHS Test and Trace Service (NHST&T) had expanded its capacity and improved its performance since a report last year found it was failing to meet its objectives.

But, there were still serious problems. During a surge in cases in December, only 17% of people received test results in 24 hours against a target of 90%, the NAO said.

Since the government embarked on a mass testing programme to find asymptomatic cases in October, 691 million lateral flow test kits had been sent out in England, but the results of only 14% - 96 million - had been returned.

The report also noted that while the government's scientific advisers said for the system to be effective no more than 48 hours should elapse between a case being identified and their contacts isolating, between January and April the median time varied between 74 and 97 hours.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The NAO said the programme, which had underspent its budget by 8.7 billion pounds, required public compliance to work, but this was "still low or variable" with only a minority of those with symptoms requesting a test or self-isolating.

"Some pressing challenges need to be tackled if it is to achieve its objectives and deliver value for taxpayers, including understanding how many lateral flow devices are actually being used and increasing public compliance with testing and self-isolation," NAO head Gareth Davies said.

A Department of Health spokesperson said the NAO had recognised improvements had been made.

“The testing and tracing being delivered across the country is saving lives every single day and helping us send this virus into retreat by breaking chains of transmission and spotting outbreaks wherever they exist," the spokesperson said.

The department said since its launch, the service had identified 3.4 million positive cases and told 7.1 million contacts to self-isolate. It said they were "finalising analysis" to understand why so few lateral flow test results were being reported.

The opposition Labour Party said the report was damning.

"The government has been told time and again that if we are going to bring down cases, it needs to ensure people can afford to self-isolate, but it has refused to listen," said its health spokesman Justin Madders.

($1 = 0.7183 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.